H. Yoshidome

发表

Cloning of rat lysosomal acid lipase cDNA and identification of the mutation in the rat model of Wolman's disease.

M. Osame, H. Nakagawa, M. Kuriyama, 1995, Journal of lipid research.

Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study.

M. Osame, K. Nakahara, I. Higuchi, 1998, Toxicology and applied pharmacology.

Familial facioscapulohumeral muscular dystrophy: phenotypic diversity and genetic abnormality

M. Nakagawa, Y. Isashiki, M. Osame, 1996, Acta neurologica Scandinavica.

Cerebrotendinous xanthomatosis: Clinical and biochemical evaluation of eight patients and review of the literature

Y. Seyama, K. Fukuda, T. Kasama, 1991, Journal of the Neurological Sciences.

Serum amyloid A and P protein levels are lowered by dextran sulfate cellulose low-density lipoprotein apheresis.

M. Osame, M. Kuriyama, J. Fujiyama, 1998, Artificial organs.

Experimental simvastatin-induced myopathy in rabbits

K. Arimura, M. Nakagawa, M. Osame, 1992, Journal of the Neurological Sciences.

[5 cases of dystonia with marked diurnal fluctuation and special reference to homovanillic acid in CSF].

M. Nomoto, M. Osame, A. Igata, 1984, Rinsho shinkeigaku = Clinical neurology.

Effects of LDL-apheresis on serum lipoprotein (a), C4b binding protein, protein C, protein S, and complement components.

M. Osame, M. Kuriyama, K. Shinmyozu, 1994, Journal of atherosclerosis and thrombosis.

Epidemiology of progressive muscular dystrophy in Okinawa, Japan. Classification with molecular biological techniques.

M. Osame, K. Nakahara, I. Higuchi, 1991, Neuroepidemiology.

Clinical findings, status of care, comprehensive quality of life, daily life therapy and treatment at home in patients with Parkinson's disease.

H. Fukunaga, H. Yoshidome, T. Kasai, 1997, European neurology.

Parkinsonism in cerebrotendinous xanthomatosis.

M. Osame, M. Kuriyama, J. Fujiyama, 1991, Japanese journal of medicine.